Secondary hyperparathyroidism (HPT) in patients receiving peritoneal dialysis (PD) can be effectively managed with cinacalcet (MIMPARA®/SENSIPAR®)

被引：0
|
作者：
Gonzalez, M. T.
Hutchison, A. J.
Girndt, M.
Stahl-Nilsson, A.
Zani, V.
Carter, D.
Molemans, B.
Bos, W. J. W.
机构：
[1] Hosp Univ Bellvitge, Barcelona, Spain
[2] Mission Res Inc, Manchester, Lancs, England
[3] Univ Saarlandes Kliniken, Homburg, Germany
[4] Lanssjukhuset Ryhov, Jonkoping, Sweden
[5] Amgen Inc, Zug, Switzerland
[6] St Antonius Hosp, Nieuwegein, Netherlands
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [41] USEFULNESS OF RADIOLOGIC EVALUATION TO PREDICT THE RESPONSE OF CINACALCET TREATMENT IN SECONDARY HYPERPARATHYROIDISM OF DIALYSIS PATIENTS
    Ah, Hong Yu
    Jee, Ko Gang
    Yeon, Jung Mi
    Sun, Cho Yoo
    Young, Oh Soo
    Hee, Seo Jae
    Jung, Pyo Heui
    Sangil, Suh
    Joo, Kwon Young
    NEPHROLOGY, 2014, 19 : 131 - 132
  • [42] Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
    Yang, Guang
    Ge, Yifei
    Zha, Xiaoming
    Mao, Huijuan
    Wang, Ningning
    Xing, Changying
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (03) : 535 - 542
  • [43] Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
    Guang Yang
    Yifei Ge
    Xiaoming Zha
    Huijuan Mao
    Ningning Wang
    Changying Xing
    International Urology and Nephrology, 2019, 51 : 535 - 542
  • [44] Cinacalcet use and risk of gastrointestinal bleeding in secondary hyperparathyroidism patients receiving maintenance hemodialysis
    Lin, Tzu-Chieh
    Guo, Haifeng
    Dluzniewski, Paul
    Peng, Yi
    Gilbertson, Dave
    Bradbury, Brian
    Nieman, Kimberly
    Sprafka, Michael
    Liu, Jiannong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 573 - 574
  • [45] Impact of Vitamin D Dose on Biochemical Parameters in Patients with Secondary Hyperparathyroidism Receiving Cinacalcet
    Wilkie, Martin
    Pontoriero, Giuseppe
    Macario, Fernando
    Yaqoob, Magdi
    Bouman, Koen
    Braun, Johann
    von Albertini, Beat
    Brink, Hans
    Maduell, Francisco
    Graf, Helmut
    Frazao, Joao M.
    Bos, Willem Jan
    Torregrosa, Vicente
    Saha, Heikki
    Reichel, Helmut
    Zani, Valter J.
    Carter, Dave
    Messa, Piergiorgio
    NEPHRON CLINICAL PRACTICE, 2009, 112 (01): : C41 - C50
  • [46] Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis
    Ross, Edward A.
    Tian, Jin
    Abboud, Hanna
    Hippensteel, Richard
    Melnick, Joel Z.
    Pradhan, Rajendra S.
    Williams, Laura A.
    Hamm, L. Lee
    Sprague, Stuart M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (01) : 97 - 106
  • [47] CALCITRIOL AND SECONDARY HYPERPARATHYROIDISM IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
    DELMEZ, JA
    PERITONEAL DIALYSIS INTERNATIONAL, 1993, 13 (02): : 95 - 97
  • [48] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Irene Ruderman
    Edward R. Smith
    Nigel D. Toussaint
    Tim D. Hewitson
    Stephen G. Holt
    BMC Nephrology, 19
  • [49] LONGITUDINAL CHANGES IN BONE AND MINERAL METABOLISM AFTER CESSATION OF CINACALCET IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Ruderman, I.
    Smith, E.
    Toussaint, N.
    Hewitson, T.
    Holt, S.
    NEPHROLOGY, 2018, 23 : 56 - 56
  • [50] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Ruderman, Irene
    Smith, Edward R.
    Toussaint, Nigel D.
    Hewitson, Tim D.
    Holt, Stephen G.
    BMC NEPHROLOGY, 2018, 19
12345